|
SPDYE3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.02409999983111E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.197900E-04 |
| Normal-vs-Stage2 |
1.181870E-02 |
| Normal-vs-Stage3 |
1.707600E-01 |
| Normal-vs-Stage4 |
6.329400E-01 |
| Stage1-vs-Stage2 |
2.478000E-01 |
| Stage1-vs-Stage3 |
3.856000E-01 |
| Stage1-vs-Stage4 |
9.022000E-02 |
| Stage2-vs-Stage3 |
8.301700E-02 |
| Stage2-vs-Stage4 |
4.295700E-02 |
| Stage3-vs-Stage4 |
5.951800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.8986700000001E-05 |
| Normal-vs-AfricanAmerican |
2.768000E-04 |
| Normal-vs-Asian |
7.386400E-01 |
| Caucasian-vs-AfricanAmerican |
2.566600E-01 |
| Caucasian-vs-Asian |
4.745600E-01 |
| AfricanAmerican-vs-Asian |
3.045400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.99429999970091E-07 |
| Normal-vs-Female |
3.081500E-03 |
| Male-vs-Female |
9.591400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.381630E-02 |
| Normal-vs-Extreme_Weight |
1.009740E-02 |
| Normal-vs-Obese |
1.756760E-03 |
| Normal-vs-Extreme_Obese |
7.253500E-02 |
| Normal_Weight-vs-Extreme_Weight |
9.936800E-01 |
| Normal_Weight-vs-Obese |
5.861400E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.626400E-01 |
| Extreme_Weight-vs-Obese |
5.650600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.422600E-01 |
| Obese-vs-Extreme_Obese |
6.106800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.804800E-03 |
| Normal-vs-Age(41-60Yrs) |
3.8659999979096E-08 |
| Normal-vs-Age(61-80Yrs) |
2.838500E-03 |
| Normal-vs-Age(81-100Yrs) |
8.124000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.574600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.512610E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.900500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.769700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.694400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.031600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.3376001962182E-10 |
| Normal-VS-Type2 PRCC |
1.879390E-01 |
| Normal-VS-KIRP CIMP |
1.728230E-01 |
| Normal-VS-Unclassified PRCC |
3.357700E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.845780E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.639400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.213040E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.832800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.347600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.221200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.838290E-02 |
| Normal-vs-N1 |
4.625400E-01 |
| Normal-vs-N2 |
3.013000E-01 |
| N0-vs-N1 |
3.076800E-01 |
| N0-vs-N2 |
2.256000E-01 |
| N1-vs-N2 |
4.015200E-01 |
|
|
